372 results
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
17 Apr 24
Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates
7:30am
drug products, drug substances, and other materials on a timely basis and in sufficient amounts; risks relating to rigorous regulatory requirements
8-K
EX-10.1
tfzydope
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
ahlo9v5
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
horj vnxc
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
rc4erkvl ksdj33
31 Jan 24
Windtree Therapeutics Announces Engagement of Strategic Advisor to Support Assessment of Strategic Alternatives
8:00am
8-K
EX-99.1
vtiq xaujrgf5
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
8-K
EX-1.1
lhr90fm6l2hc5
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
uee1mug7gk
9 Nov 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
u78z9n
7 Aug 23
Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates
4:02pm
DEFA14A
ui5t3mkj7 hi8vus6mnb
29 Jun 23
Additional proxy soliciting materials
5:37pm
DEFA14A
l1uc9554vg5in6tgk
29 Jun 23
Additional proxy soliciting materials
5:35pm